Anavex Life Sciences Corp (AVXL)

[Bourbon_on_my_cornflakes]

Maxim's AVXL price target $15 share

Maxim cites these Catalysts:
• Initiate Phase 2 clinical trial in Rett syndrome (12-week, randomized, double-blind,
placebo-controlled).
• Initiate Phase 2 clinical trial in Parkinson’s disease (12-week, randomized, doubleblind,
placebo-controlled).
• Initiate Phase 2/3 clinical trial in Alzheimer’s disease (6/12-month, randomized,
double-blind, placebo-controlled).
• Potential for several clinical read-outs in 2018.
• Complement current pipeline through in-licensing – ongoing

the last comment is interesting...implies licensing negotiations ongoing?